BioValeo is a leading brand in the field of clinical research, specializing in precision medicine. With a team of highly experienced clinical research professionals, BioValeo delivers innovative and successful clinical trials for their clients. As a trusted partner for pharmaceutical and biotechnology companies, BioValeo provides pioneering solutions that drive the development of personalized treatments for patients worldwide.

BioValeo's mission is to advance personalized medicine through expertly designed and executed clinical trials. As a bespoke CRO (Contract Research Organization), they offer tailored solutions to their clients, utilizing the latest technologies, methodologies, and knowledge to ensure the safety and efficacy of new treatments for patients. They strive to build lasting partnerships with their clients, fostering open communication and collaboration to deliver the best possible results.

Supported by Bridgewest Ventures NZ LP, BioValeo benefits from deep technology experience and extensive connections, allowing them to transform innovative opportunities into world-class companies. They are also part of Callaghan Innovation's Technology Incubator Programme, which activates innovation and helps businesses grow faster. Partnered with BioOra, BioViros, Bio4t2, and BioCina, BioValeo has access to licensed contract manufacturers and innovative therapies, expanding their capabilities to bring cutting-edge treatments to patients.

To learn more about how BioValeo can help, visit their website and get in touch with them today